Heart failure in women

Medical Clinics of North America

Volumn 88, Issue 5, 2004, Pages 1321-1345

  Lund, Lars H ^a   Mancini, Donna ^a,b  

^a Columbia Univ Coll Phys Surgs ^*  (United States)

^b Och Spine at New York Presbyterian Hospitals   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; ALDOSTERONE ANTAGONIST; ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CAPTOPRIL; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRIL; HYDRALAZINE; LOSARTAN; NITRATE; RAMIPRIL; SEX HORMONE;

AGE DISTRIBUTION; AGING; CAUSE OF DEATH; CLINICAL FEATURE; CONGESTIVE CARDIOMYOPATHY; CORONARY ARTERY DISEASE; DIABETES MELLITUS; DIAGNOSTIC PROCEDURE; DIASTOLE; EPIDEMIOLOGICAL DATA; EXERCISE; FEMALE; GENDER; HEART EJECTION FRACTION; HEART FAILURE; HEART INFARCTION; HEART TRANSPLANTATION; HEART VENTRICLE PRESSURE; HORMONE ACTION; HUMAN; HYPERTENSION; INJURY; ISCHEMIC HEART DISEASE; MALE; METABOLIC SYNDROME X; MORBIDITY; MORTALITY; OBESITY; PATHOGENESIS; PHYSICAL ACTIVITY; PRIORITY JOURNAL; REVIEW; SEX DIFFERENCE; SURVIVAL; SYSTOLE;

ADULT; AGE DISTRIBUTION; AGED; CARDIOVASCULAR AGENTS; CAUSE OF DEATH; CLINICAL TRIALS; CORONARY DISEASE; DEATH, SUDDEN, CARDIAC; EPIDEMIOLOGIC STUDIES; FEMALE; GONADAL STEROID HORMONES; HEART FAILURE, CONGESTIVE; HUMANS; HYPERTENSION; MIDDLE AGED; PATIENT SELECTION; PROGNOSIS; RISK FACTORS; SEX CHARACTERISTICS; SEX DISTRIBUTION; SEX FACTORS; SURVIVAL RATE; TREATMENT OUTCOME; UNITED STATES; WOMEN'S HEALTH;

EID: 4444236078     PISSN: 00257125     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mcna.2004.03.003     Document Type: Review

References (100)

1. McKee P.A., Castelli W.P., McNamara P.M., Kannel W.B. The natural history of congestive heart failure: The Framingham Study. N Engl J Med. 285:(26):1971;1441-1445
2. Smith W.M. Epidemiology of congestive heart failure. Am J Cardiol. 55:1985;3A-8A
3. Gillum R.F. Heart failure in the United States 1970-1985. Am Heart J. 113:1987;1043-1045
4. Kannel W.B. Epidemiological aspects of heart failure. Cardiol Clin. 7:(1):1989;1-9
5. Shocken D.D., Arrieta M.I., Leaverton P.E. Prevalence and mortality rate of congestive heart failure in the United States. J Am Coll Cardiol. 20:(2):1992;301-306
6. Ho K.K.L., Pinsky J.L., Kannel W.B., Levy D. The epidemiology of heart failure: the Framingham Study. J Am Coll Cardiol. 22:(Suppl A):1993;6A-13A
7. He J., Ogden L., Bazzano L.A., Vupputuri S., Loria C., Whelton P.K. Risk factors for congestive heart failure in US men and women. Arch Intern Med. 161:2001;996-1002
8. Levy D., Kenchaiah S., Larson M.G., Benjamin E.J., Kupka M.J., Ho K.K.L., et al. Long-term trends in the incidence of and survival with heart failure. N Engl J Med. 347:2002;1397-1402
9. Ni H. Prevalence of self-reported heart failure among US adults: Results from the 1999 National Health Interview Survey. Am Heart J. 146:(1):2003;121-128
10. American Heart Association. Heart disease and stroke statistics - 2003 update. Available at: http://www.americanheart.org/presenter.jhtml?identifier= 1928 and http://www.americanheart.org/presenter.jhtml?identifier=2007. Accessed 2003.
11. Ho K.K.L., Anderson K.M., Kannel W.B., Grossman W., Levy D. Survival after the onset of congestive heart failure in Framingham Heart Study subjects. Circulation. 88:1993;107-115
12. Felker G.M., Thompson R.E., Hare J.M., Hruban R.H., Clemetson D.E., Howard D.L., et al. Underlying causes and long-term survival in patients with initially unexplained cardiomyopathy. N Engl J Med. 342:(15):2003;1077-1084
13. Jessup M., Brozena S. Heart failure. N Engl J Med. 348:(20):2003;2007- 2018
14. Bourassa M.G., Gurne O., Bangdiwala S.I., Ghali J.K., Young J.B., Rousseau M., et al. Natural history and patterns of current practice in heart failure. J Am Coll Cardiol. 22:(Suppl A):1993;14A-19A
15. Philbin E.F., DiSalvo T.G. Influence of race and gender on care process, resource use, and hospital-based outcomes in congestive heart failure. Am J Cardiol. 82:1998;76-81
16. Petrie M.C., Dawson N.F., Murdoch D.R., Davie A.P., McMurray J.J.V. Failure of women's hearts. Circulation. 99:1999;2334-2341
17. Vasan R.S., Larson M.G., Benjamin E.J., Evans J.C., Reiss C.K., Levy D. Congestive heart failure in subjects with normal versus reduced left ventricular ejection fraction: prevalence and mortality in a population-based cohort. J Am Coll Cardiol. 33:1999;1948-1955
18. MacIntyre K., Capewell S., Stewart S., Chalmers J.W.T., Boyd J., Finlayson A., et al. Evidence of improving prognosis in heart failure; trends in case fatality in 66,547 patients hospitalized between 1986 and 1995. Circulation. 102:2000;1126-1131
19. Mosterd A., Cost B., Hoes A.W., de Bruijne M.C., Deckers J.W., Hofman A., et al. The prognosis of heart failure in the general population. The Rotterdam Study. Eur Heart J. 22:2001;1318-1327
20. Rathore S.S., Wang Y., Krumholtz H.M. Sex-based differences in the effect of digoxin for the treatment of heart failure. N Engl J Med. 347:(18):2002;1403-1411
21. Pfeffer M.A., Braunwald E., Moye L.A., Basta L., Brown E.J., Cuddy T.E., et al. Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. N Engl J Med. 327:(10):1992;669-677
22. Ghali J.K., Pina I.L., Gottlieb S.S., Deedwania P.C., Wikstrand J.C. Metoprolol CR/XL in female patients with heart failure: analysis of the experience in Metoprolol Extended-Release Randomized Intervention Trial in Heart Failure (MERIT-HF). Circulation. 105:2002;1585-1591
23. Simon T., Mary-Krause M., Funck-Brentano C., Jaillon P. Sex differences in the prognosis of congestive heart failure: results from the Cardiac Insufficiency Bisoprolol Study (CIBIS II). Circulation. 103:2001;375-380
24. Swedberg K., Held P., Kjekshus J., Rasmussen K., Ryden L., Wedel H. Effects of the early administration of enalapril on mortality in patients with acute myocardial infarction: results of the Cooperative New Scandinavian Enalapril Survival Study II (CONSENSUS II). N Engl J Med. 327:(10):1992;678-684
25. Kober L., Torp-Pedersen C., Carlsen J.E., Bagger H., Eliasen P., Lyngborg K., et al. A clinical trial of the angiotensin-converting enzyme inhibitor trandolapril in patients with left ventricular dysfunction after myocardial infarction. N Engl J Med. 333:(25):1995;1670-1676
26. Packer M., Bristow M.R., Cohn J.N., Colucci W.S., Fowler M.B., Gilbert E.M., et al. The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. N Engl J Med. 334:(21):1996;1349-1355
27. The SOLVD Investigators. Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. N Engl J Med. 325:(5):1991;293-302
28. The SOLVD Investigators. Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fraction. N Engl J Med. 327:(10):1992;685-691
29. MERIT-HF Study Group. Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in congestive Heart Failure (MERIT-HF). Lancet. 353:1999;2001-2007
30. Kannel W.B., Wilson P.W., D'Agostino R.B., Cobb J. Sudden coronary death in women. Am Heart J. 136:1998;205-212
31. Cooper R., Cutler J., Desvigne-Nickens P., Fortmann S.P., Friedman L., Havlik R., et al. Trends and disparities in coronary heart disease, stroke, and other cardiovascular diseases in the United States. Circulation. 102:2000;3137-3147
32. Lorell B.H., Stevenson L.W. Congestive Heart Failure. Wilansky S., Willerson J.T. Heart disease in women. 2002;311-319 Elsevier Science, Philadelphia
33. Johnstone D., Limacher M., Rousseau M., Liang C.S., Ekelund L., Herman M., et al. Clinical characteristics of patients in Studies of Left Ventricular Dysfunction (SOLVD). Am J Cardiol. 70:1992;894-900
34. Gan S.C., Beaver S.K., Houck P.M., MacLehose R.F., Lawson H.W., Chan L. Treatment of acute myocardial infarction and 30-day mortality among women and men. N Engl J Med. 343:(1):2000;8-15
35. Hoffman R.M., Psaty B.M., Kronmal R.A. Modifiable risk factors for incident heart failure in the Coronary Artery Surgery Study. Arch Intern Med. 154:1994;417-423
36. O'Connor G.T., Morton J.R., Diehl M.J., Olmstead E.M., Coffin L.H., Levy D.G., et al. Differences between men and women in hospital mortality associated with coronary artery bypass graft surgery. Circulation. 88:1993;2104-2110
37. Levy D., Larson M.G., Vasan R.S., Kannel W.B., Ho K.K. The progression of hypertension to congestive heart failure. JAMA. 275:(20):1996;1557-1562
38. Senni M., Redfield M.M. Heart failure with preserved systolic function. J Am Coll Cardiol. 38:2001;1277-1282
39. Hunt S.A., Baker D.W., Chin M.H., Cinquegrani M.P., Feldman A.M., Francis G.S., et al. ACC/AHA guidelines for the evaluation and management of chronic heart failure in the adult. Executive Summary. J Am Coll Cardiol. 38:(7):2001;2101-2113
40. Zile M.R., Brutsaert D.L. New concepts in diastolic dysfunction and diastolic heart failure Part I. Diagnosis, prognosis, and measurements of diastolic function. Circulation. 105:2002;1387-1393
41. Gottdiener J.S., McClelland R.L., Marshall R., Shemanski L., Furberg C.D., Kitzman D.W., et al. Outcome of congestive heart failure in elderly persons: influence of left ventricular systolic function: The Cardiovascular Health Study. Ann Intern Med. 137:(8):2002;631-639
42. Beniaminovitz A., Mancini D.M. Congestive heart failure. coronary artery disease in women: what all physicians need to know. 1999;476-495 American College of Physicians-American Society of Internal Medicine, Philadelphia
43. Malhotra A., Buttrick P., Scheuere J. Effects of sex hormones on the development physiologic and pathologic cardiac hypertrophy in male and female rats. Am J Physiol. 259:(3 Pt 2):1990;H866-H871
44. Levy D., Savage D.D., Garrison R.J., Anderson K.M., Kannel W.B., Castelli W.P. Echocardiographic criteria for left ventricular hypertrophy: The Framingham Heart Study. Am J Cardiol. 59:1987;956-960
45. Topol E.J., Traill T.A., Fortuin N.J. Hypertensive hypertrophic cardiomyopathy of the elderly. N Engl J Med. 312:(5):1985;277-283
46. Weinberg E.O., Thienelt C.D., Katz S.E., Bartunek J., Tajima M., Rohrbach S., et al. Gender differences in molecular remodeling in pressure overload hypertrophy. J Am Coll Cardiol. 34:1999;264-273
47. Kadokami T., McTiernan C.F., Kubota T., Frye C.S., Feldman A.M. Sex-related survival differences in murine cardiomyopathy are associated with differences in TNF-receptor expression. J Clin Invest. 106:2000;589-597
48. Lieberman E.H., Gerhard M.D., Uehata A., Walsh B.W., Selwyn A.P., Ganz P., et al. Estrogen improves endothelium-dependent, flow-mediated vasodilation in postmenopausal women. Ann Int Med. 121:1994;936-941
49. Dubey R.K., Oparil S., Imthurn B., Jackson E.K. Sex hormones and hypertension. Cardiovasc Res. 53:2002;688-708
50. Schaible T.F., Malhotra A., Ciambrone G., Scheuer J. The effects of gonadectomy on left ventricular function and cardiac contractile proteins in male and female rats. Circ Res. 54:1984;38-49
51. Scheuer J., Malhotra A., Schaible T.F., Capasso J. Effects of gonadectomy and hormonal replacement on rat hearts. Circ Res. 61:1987;12-19
52. Coughlin S.S., Tefft M.C. The epidemiology of idiopathic dilated cardiomyopathy in women: the Washington DC Dilated Cardiomyopathy Study. Epidemiology. 5:(4):1994;449-455
53. Reis S.E., Holubkov R., Young J.B., White B.G., Cohn J.N., Feldman A.M. Estrogen is associated with improved survival in aging women with congestive heart failure: analysis of the vesnarinone studies. J Am Coll Cardiol. 36:2000;529-533
54. Manson J.E., Hsia J., Johnson K.C., Rossouw J.E., Assaf A.R., Lasser N.L., et al. Estrogen plus progestin and the risk of coronary heart disease. N Engl J Med. 349:(6):2003;523-534
55. Hulley S., Grady D., Bush T., Furberg C., Herrington D., Riggs B., et al. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group. JAMA. 280:(7):1998;605-613
56. Galderisi M., Anderson K.M., Wilson P.W.F., Levy D. Echocardiographic evidence for the existence of a distinct diabetic cardiomyopathy (The Framingham Heart Study). Am J Cardiol. 68:1991;85-89
57. Devereux R.B., Roman M.J., Paranicas M., O'Grady M.J., Lee E.T., Welty T.K., et al. Impact of diabetes on cardiac structure and function. Circulation. 101:2000;2271-2276
58. Zarich S.W., Nesto R.W. Diabetic cardiomyopathy. Am Heart J. 118:1989;1000-1012
59. Nichols G.A., Hillier T.A., Erbey J.R., Brown J.B. Congestive heart failure in type 2 diabetes. Diabetes Care. 24:(9):2001;1614-1619
60. Iribarren C., Karter A.J., Go A.S., Ferrara A., Liu J.Y., Sidney S., et al. Glycemic control and heart failure among adult patients with diabetes. Circulation. 103:(22):2001;2668-2673
61. Kannel W.B., Hjortland M., Castelli W.P. Role of diabetes in congestive heart failure: the Framingham Study. Am J Cardiol. 34:(1):1974;29-34
62. Shindler D.M., Kostis J.B., Yusuf S., Quinones M.A., Pitt B., Stewart D., et al. Diabetes mellitus, a predictor of morbidity and mortality in the Studies of Left Ventricular Dysfunction (SOLVD) trials and registry. Am J Cardiol. 77:1996;1017-1020
63. Kenchaiah S., Evans J.C., Levy D., Wilson P.W.F., Benjamin E.J., Larson M.G., et al. Obesity and the risk of heart failure. N Engl J Med. 347:(5):2002;305-313
64. Remes J., Miettinen H., Reunanen A., Pyorala K. Validity of clinical diagnosis of heart failure in primary health care. Eur Heart J. 12:1991;315-321
65. Massie B.M. Obesity and heart failure - risk factor or mechanism? N Engl J Med. 347:(5):2002;358-359
66. Pearson T.A. Alcohol and heart disease. Circulation. 94:1996;3023-3025
67. Fernandez-Sola J., Estruch R., Nicolas J.M., Pare J.C., Sacanella E., Antunez E., et al. Comparison of alcoholic cardiomyopathy in women versus men. Am J Cardiol. 80:1997;481-485
68. Codd M.B., Sugrue D.D., Gersh B.J., Melton L.J. Epidemiology of idiopathic dilated and hypertrophic cardiomyopathy. Circulation. 80:1989;564-572
69. Bagger J.P., Baandrup U., Rasmussen K., Moller M., Vesterlund T. Cardiomyopathy in western Denmark. Br Heart J. 52:(3):1984;327-331
70. De Maria R., Gavazzi A., Recalcati F., Baroldi G., De Vita C., Camerini F. Comparison of clinical findings in idiopathic dilated cardiomyopathy in women versus men. Am J Card. 72:1993;580-585
71. Mancini D.M., Eisen H., Kussmaul W., Mull R., Edmunds L.H. Jr., Wilson J.R. Value of peak exercise oxygen consumption for optimal timing of cardiac transplantation in ambulatory patients with heart failure. Circulation. 83:1991;778-786
72. Aaronson K.D., Mancini D.M. Is percentage of predicted maximal exercise oxygen consumption a better predictor of survival than peak exercise oxygen consumption for patients with severe heart failure? J Heart Lung Transplant. 14:(5):1995;981-989
73. Sullivan M.J., Cobb F.R., Higginbotham M.B. Stroke volume increases by similar mechanisms during upright exercise in normal men and women. Am J Cardiol. 67:1991;1405-1412
74. Kjeldsen S.E., Dahlof B., Devereux R.B., Julius S., Aurup P., Edelman J., et al. Effects of losartan on cardiovascular morbidity and mortality in patients with isolated systolic hypertension and left ventricular hypertrophy. JAMA. 288:2002;1491-1498
75. Hillis G.S., Trent R.J., Winton P., MacLeod A.M., Jennings K.P. Angiotensin-converting enzyme inhibitors in the management of cardiac failure: are we ignoring the evidence? Q J Med. 89:1996;145-152
76. Chin M.H., Goldman L. Factors contributing to the hospitalization of patients with congestive heart failure. Am J Public Health. 87:(4):1997;648
77. Havranek E.P., Abrams F., Stevens E., Parker K. Determinants of mortality in elderly patients with heart failure. Arch Intern Med. 158:1998;2024-2028
78. Monane M., Bohn R.L., Gurwitz J.H., Glynn R.J., Avorn J. Noncompliance with congestive heart failure therapy in the elderly. Arch Intern Med. 154:(4):1994;433-437
79. Cohn J.N., Johnson G., Ziesche S., Cobb F., Francis G., Tristani F., et al. A comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure. N Engl J Med. 325:1991;303-310
80. The CONSENSUS Trial Study Group. Effects of enalapril on mortality in severe congestive heart failure. N Engl J Med. 316:(23):1987;1429-1435
81. Arnold J.M.O., Yusuf S., Young J., Mathew J., Johnstone D., Avezum A., et al. Prevention of heart failure in patients in the Heart Outcomes Evaluation (HOPE) study. Circulation. 107:2003;1284-1290
82. Kimmelstiel C., Goldeberg R.J. Congestive heart failure in women: focus on heart failure due to coronary artery disease and diabetes. Cardiology. 77:(Suppl 2):1990;S71-S79
83. Wenger N.K., Speroff L., Packard B. Cardiovascular health and disease in women. N Engl J Med. 329:(4):1993;247-253
84. The Acute Infarction Ramipril Efficacy (AIRE) Study Investigators. Effect of ramipril on mortality and morbidity of survivors of acute myocardial infarction with clinical evidence of heart failure. Lancet. 342:1993;821-828
85. Garg R., Yusuf S. Overview of randomized trials of angiotensin-converting enzyme inhibitors on mortality and morbidity in patients with heart failure. JAMA. 273:1995;1450-1456
86. Flather M.D., Yusuf S., Kober L., Pfeffer M., Hall A., Murray G., et al. Long-term ACE-inhibitor therapy in patients with heart failure of left-ventricular dysfunction: a systematic overview of data from individual patients. Lancet. 355:2000;1575-1581
87. Kostis J.B., Shelton B., Gosselin G., Goulet C., Hood W.B. Jr., Kohn R.M., et al. Adverse effects of enalapril in the Studies of Left Ventricular Dysfunction (SOLVD). Am Heart J. 131:(2):1996;350-355
88. Exner D.V., Dries D.L., Domanski M.J., Cohn J.N. Lesser response to angiotensin-converting-enzyme inhibitor therapy in black as compared with white patients with left ventricular dysfunction. N Engl J Med. 344:(18):2001;1351- 1357
89. Pfeffer M.A., Braunwald E., Moye L.A. ACE inhibitors after myocardial infarction. [reply] N Engl J Med. 328:(13):1993;968
90. Pitt B., Poole-Wilson P.A., Segal R., Martinez F.A., Dickstein K., Camm A.J., et al. Effect of losartan compared with captopril on mortality in patients with symptomatic heart failure: randomized trial - the Losartan Heart Failure Survival Study ELITE II. Lancett. 355:2000;1582-1587
91. Cohn J.N., Tognoni G. A randomized trial of the angiotensin-receptor blocker valsartan in chronic heart failure. N Engl J Med. 345:(23):2001;1667- 1675
92. Leizorovicz A., Lechat P., Cucherat M., Bugnard F. Bisoprolol for the treatment of chronic heart failure: A meta-analysis of individual data of two placebo-controlled studies - CIBIS and CIBIS II. Am Heart J. 143:2002;301-307
93. Packer M., Coats A.J.S., Fowler M.B., Katus H.A., Krumholtz H., Mohacsi P., et al. Effect of carvedilol on survival in severe chronic heart failure. N Engl J Med. 344:(22):2001;1651-1658
94. Pitt B., Zannad F., Remme W.J., Cody R., Castaigne A., Perez A., et al. The effect of spironolactone on morbidity and mortality in patients with severe heart failure. N Engl J Med. 341:(10):1999;709-717
95. Pitt B., Remme W., Zannad F., Neaton J., Martinez P., Roniker B., et al. Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction. N Engl J Med. 348:(14):2003;1309-1321
96. Taylor D.O., Edwards L.B., Mohacsi P.J., Boucek M.M., Trulock E.P., Keck B.M., et al. The registry of the International Society for Heart and Lung Transplantation: Twentieth official adult heart transplant report - 2003. J Heart Lung Transplant. 22:2003;616-624
97. Stevenson W.G., Stevenson L.W., Middlekauff H.R., Fonarow G.C., Hamilton M.A., Woo M.A., et al. Improving survival for patients with advance heart failure: a study of 737 consecutive patients. J Am Coll Cardiol. 26:1995;1417-1423
98. Aaronson K.D., Schwartz J.S., Goin J.E., Mancini D.M. Sex differences in patient acceptance of cardiac transplant candidacy. Circulation. 91:1995;2752-2761
99. Esmore D., Keogh A., Spratt P., Jones B., Chang V. Heart transplantation in females. J Heart Lung Transplant. 10:1991;335-341
100. Wechsler M.E., Giardina E.G.V., Sciacca R.R., Rose E.A., Barr M.L. Increased early mortality in women undergoing cardiac transplantation. Circulation. 91:1995;1029-1035